Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): Susceptibility to Candida albicans infection and leucocyte function

Journal of Medical Microbiology

Volumn 44, Issue 4, 1996, Pages 277-283

  Plotkin, B J ^a   Paulson, D ^a   Chelich, A ^b   Jurak, D ^a   Cole, J ^a   Kasimos, J ^a   Burdick, J R ^a   Casteel, N ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b PURDUE UNIVERSITY CALUMET   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; LEUKOCYTE FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0029930468     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-4-277     Document Type: Article

References (37)

1. Bray GA. Complications of obesity. Ann Int Med 1985; 103: 1052-1062.
2. Budayr A, Feingold K. Dermatologic complications of diabetes: IX. Clin Diabetes 1990; 8: 12-13.
3. Chandra RK. Immune response in overnutrition. Cancer Res 1981; 41: 3795-3796.
4. Huntley AC. The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982; 7: 427-455.
5. Siperstein MD. Type II diabetes: some problems in diagnosis and treatment. Hosp Pract 1985; 20: 55-63.
6. Stern MP, Patterson JK, Haffner SM, Hazuda HP, Mitchell BD. Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 1989; 262: 360-364.
7. Thorton GF. Infections and diabetes. Med Clin North Am 1971; 55: 931-938.
8. Bray GA. The Zucker-fatty rat: a review. Federation Proceed 1977; 36: 148-153.
9. Triscari J, Stem JS, Johnson PR, Sullivan AC. Carbohydrate metabolism in lean and obese Zucker rats. Metabolism 1979; 28: 183-189.
10. Burstein M, Samaille J. Sur un dosage rapide du cholesterol lié aux a et aux β-lipoprotéines du sérum. Clin Chim Acta 1960; 5: 609.
11. Grocott RG. A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic. Am J Clin Pathol 1955; 25: 975-979.
12. Kolotila MP, Smith CW, Rogers AL. Candidacidal activity of macrophages from three mouse strains as demonstrated by a new method: neutral red staining. J Med Vet Mycol 1987; 25: 283-290.
13. Marodi L, Korchak HM, Johnston RB. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 1991; 146: 2783-2789.
14. Peterson EM, Calderone RA. Growth inhibition of Candida albicans by rabbit alveolar macrophages. Inject Immun 1977; 15: 910-915.
15. Bray GA, York DA. Genetically transmitted obesity in rodents. Physiol Rev 1971; 51: 598-646.
16. Briscoe HF, Allison F. Diabetes and host resistance I. Effect of alloxan diabetes upon the phagocytic and bactericidal efficiency of rat leukocytes for pneumococcus. J Bacterial 1965; 90: 1537-1541.
17. Chandra RK. Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice. Am J Clin Nutr 1980; 33: 13-16.
18. Melez KA, Attalah AM, Harrison ET, Raveche ES. Immune abnormalities in the diabetic New Zealand obese (NZO) mouse: insulin treatment partially suppresses splenic hyper-activity measured by flow cytometric analysis. Clin Immunol Immunopathol 1985; 36: 110-119.
19. Pasko K, Salvin SB, Winkelstein A. Mechanisms in the in vivo release of lymphokines: V. responses in alloxan-treated and genetically diabetic mice. Cell Immunol 1981; 62: 205-219.
20. Pierce GN, Beamish RE, Dhalla NS. Research models of diabetes mellitus. In: Heart dysfunction in diabetes. Boca Raton, FL, CRC Press Inc. 1988: 23-50.
21. Sheena J, Meade CJ. Mice bearing the ob/ob mutation have impaired immunity. Int Arch Allergy Appl Immunol 1978; 57: 263-268.
22. Mosci P, Vecchiarelli A, Cenci E, Puliti M, Bistoni F. Low-dose streptozotocin-induced diabetes in mice. I. Course of Candida albicans infection. Cell Immunol 1993; 150: 27-35.
23. Reaven G. Insulin-independent diabetes mellitus: metabolic characteristics. Metabolism 1980; 29: 445-454.
24. Kolterman OG, Olefsky JM, Kurahara C, Taylor K. A defect in cell-mediated immune function in insulin-resistant diabetic and obese subjects. J Lab Clin Med 1980; 96: 535-543.
25. Odds FC. In: Candida and candidiasis. A review and bibliography, 2nd edn. Philadelphia, Balliere Tindall. 1988: 42-59.
26. Rotrosen D, Calderone RA, Edwards JE. Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1986; 8: 73-85.
27. Brawner DL, Cutler JE. Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect Immun 1986; 51: 337-343.
28. Torosantucci A, Boccanera M, Casalinuovo I, Pellegrini G, Cassone A. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. J Gen Microbiol 1990; 136: 1421-1428.
29. Blasi E, Pitzurra L, Puliti M, Lanfrancone L, Bistoni F. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun 1992; 60: 832-837.
30. Dobias B. Specific and nonspecific immunity in candida infections. Experimental studies of the role of candida cell constituents and review of literature. Acta Medica Scand 1964; 176 Suppl 421: 5-79.
31. Diamond RD. Immune response to fungal infection. Rev Infect Dis 1989; 11 Suppl 7: S1600-1604.
32. Murphy JW. Natural host resistance mechanisms against systemic mycotic agents. In: Functions of the natural immune system. Reynolds CW, Wiltrout RH (eds) NY, Plenum Press, 1990: 149-184.
33. Djeu JY. Cytokines and anti-fungal immunity. Adv Exp Med Biol 1992; 319: 217-223.
34. Stanley V, Hurley R. The growth of Candida species in cultures of mouse peritoneal macrophages. J Pathol 1969; 97: 357-366.
35. Dianzani MU, Torrielli MV, Canuto RA, Garcea R, Feo F. The influence of enrichment with cholesterol on the phagocytic activity of rat macrophages. J Pathol 1976; 118: 193-199.
36. Gilbreath MJ, Nacy CA, Hoover DL, Airing CR, Swartz GM, Meltzer M. Macrophage activation for microbicidal activity against Leishmania major, inhibition of lymphokine activation by phosphatidylcholine-phosphotidylserine liposomes. J Immunol 1985; 134: 3420-3425.
37. Montgomery RR, Cohn ZA. Endocytic and secretory repertoire of the lipid-loaded macrophage. J Leukoc Biol 1989; 45: 129-138.